/ clinic study
Why Ventyx Biosciences Stock (VTYX) Skyrocketed 105% Today?
Ventyx shares soared 105% on Phase 2 results demonstrating rapid 80% reduction in key heart disease markers.
October 23, 2025Why did ABVX Surge Over 400% in Premarket Trading?
Abivax shares surged over 400% in premarket trading after announcing positive Phase 3 results for its ulcerative colitis drug obefazimod.
July 23, 2025